Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
104 studies found for:    aspirin | United States, New York | Studies with Male Participants
Show Display Options
Rank Status Study
21 Completed Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
Conditions: Common Cold;   Pharyngitis
Interventions: Drug: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine;   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Pseudoephedrine;   Drug: Placebo
22 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
23 Recruiting Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Aspirin
24 Completed Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
25 Completed
Has Results
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Condition: Stroke
Interventions: Drug: Aggrenox;   Drug: Clopidogrel placebo;   Drug: Micardis;   Drug: Aggrenox placebo;   Drug: Clopidogrel;   Drug: Micardis placebo
26 Active, not recruiting
Has Results
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Coronary Stent System;   Device: PROMUS Element Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine
27 Active, not recruiting TAXUS Libertē Post Approval Study
Condition: Coronary Artery Disease
Interventions: Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
28 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
29 Active, not recruiting PROMUS Element Plus US Post-Approval Study
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus Coronary Stent System;   Drug: Aspirin;   Drug: P2Y12 antagonist
30 Recruiting Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin
31 Completed
Has Results
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Condition: Increased Drug Resistance
Interventions: Drug: Aspirin;   Drug: Lovaza;   Drug: Both Aspirin and Lovaza;   Other: Placebo
32 Completed Fish Oil and Aspirin With Type 2 Diabetes
Condition: Cardiovascular Disease
Intervention: Dietary Supplement: Fish Oil and Aspirin
33 Recruiting Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
Conditions: Peripheral Artery Disease;   Type 2 Diabetes
Interventions: Drug: Aspirin;   Drug: Ticagrelor;   Drug: Aspirin Placebo;   Drug: Ticagrelor Placebo
34 Completed Warfarin Versus Aspirin Recurrent Stroke Study
Condition: Stroke
Interventions: Drug: Active Aspirin;   Drug: Active Warfarin;   Drug: Aspirin placebo;   Drug: Warfarin placebo
35 Recruiting Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease (AERD)
Interventions: Drug: Ifetroban, Oral Capsule;   Drug: Placebo, Oral Capsule
36 Not yet recruiting Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
Conditions: Cardiovascular Disease;   Interventional Cardiology
Interventions: Drug: Aspirin;   Drug: Placebo;   Drug: ticagrelor
37 Unknown  Effects of Pioglitazone on Platelet Function
Conditions: Diabetes;   Platelet Aggregation;   Healthy
Interventions: Drug: pioglitazone and aspirin;   Drug: Pioglitazone;   Drug: Pioglitazone + 81mg Aspirin
38 Unknown  Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease
Intervention:
39 Recruiting Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
40 Recruiting LIPS-A: Lung Injury Prevention Study With Aspirin
Condition: Acute Respiratory Distress Syndrome
Interventions: Drug: Aspirin;   Drug: Lactose powder

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years